<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:webfeeds="http://webfeeds.org/rss/1.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>eLife: latest articles by subject</title>
    <link>https://elifesciences.org</link>
    <description>Articles published by eLife, filtered by given subjects</description>
    <atom:link href="https://observer.elifesciences.org/report/latest-articles-by-subject" rel="self"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>observer (using python-feedgen)</generator>
    <language>en</language>
    <lastBuildDate>Thu, 16 Apr 2026 17:32:31 +0000</lastBuildDate>
    <webfeeds:analytics id="G-TZ0BM7CV5E" engine="GoogleAnalytics"/>
    <item>
      <title>Correction: Opposing p53 and mTOR/AKT promote an in vivo switch from apoptosis to senescence upon telomere shortening in zebrafish</title>
      <link>https://elifesciences.org/articles/111193</link>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.111193</guid>
      <category>Cell Biology</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Wed, 04 Mar 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-03-04T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Branched actin polymerization drives invasive protrusion formation to promote myoblast fusion during mouse skeletal muscle regeneration</title>
      <link>https://elifesciences.org/articles/103550</link>
      <description>Skeletal muscle regeneration is a multistep process involving the activation, proliferation, differentiation, and fusion of muscle stem cells, known as satellite cells. Fusion of satellite cell-derived myoblasts (SCMs) is indispensable for generating the multinucleated, contractile myofibers during muscle repair. However, the molecular and cellular mechanisms underlying SCM fusion during muscle regeneration remain incompletely understood. Here, we reveal a critical role for branched actin polymerization in SCM fusion during mouse skeletal muscle regeneration. Using conditional knockouts of the Arp2/3 complex and its actin nucleation-promoting factors N-WASP and WAVE, we demonstrate that branched actin polymerization is specifically required for SCM fusion but dispensable for satellite cell proliferation, differentiation, and migration. We show that the N-WASP and WAVE complexes have partially redundant functions in regulating SCM fusion and that branched actin polymerization is essential for generating invasive protrusions at fusogenic synapses in SCMs. Together, our study identifies branched-actin regulators as key components of the myoblast fusion machinery and establishes invasive protrusion formation as a critical mechanism enabling myoblast fusion during skeletal muscle regeneration.</description>
      <author>yue.lu@utsouthwestern.edu (Christa W Habela)</author>
      <author>yue.lu@utsouthwestern.edu (Chuanli Zhou)</author>
      <author>yue.lu@utsouthwestern.edu (Elizabeth H Chen)</author>
      <author>yue.lu@utsouthwestern.edu (Pratima Pandey)</author>
      <author>yue.lu@utsouthwestern.edu (Rong Li)</author>
      <author>yue.lu@utsouthwestern.edu (Scott B Snapper)</author>
      <author>yue.lu@utsouthwestern.edu (Tezin Walji)</author>
      <author>yue.lu@utsouthwestern.edu (Yue Lu)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.103550</guid>
      <category>Developmental Biology</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Thu, 29 Jan 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-01-29T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Directed differentiation of functional corticospinal-like neurons from endogenous SOX6+/NG2+ cortical progenitors</title>
      <link>https://elifesciences.org/articles/100340</link>
      <description>Corticospinal neurons (CSN) centrally degenerate in amyotrophic lateral sclerosis (ALS), along with spinal motor neurons, and loss of voluntary motor function in spinal cord injury (SCI) results from damage to CSN axons. For functional regeneration of specifically affected neuronal circuitry &lt;i&gt;in vivo&lt;/i&gt;, or for optimally informative disease modeling and/or therapeutic screening &lt;i&gt;in vitro&lt;/i&gt;, it is important to reproduce the type or subtype of neurons involved. No such appropriate &lt;i&gt;in vitro&lt;/i&gt; models exist with which to investigate CSN selective vulnerability and degeneration in ALS, or to investigate routes to regeneration of CSN circuitry for ALS or SCI, critically limiting the relevance of much research. Here, we identify that the HMG-domain transcription factor &lt;i&gt;Sox6&lt;/i&gt; is expressed by a subset of NG2+ endogenous cortical progenitors in postnatal and adult cortex, and that &lt;i&gt;Sox6&lt;/i&gt; suppresses a latent neurogenic program by repressing proneural &lt;i&gt;Neurog2&lt;/i&gt; expression by progenitors. We FACS-purify these progenitors from postnatal mouse cortex and establish a culture system to investigate their potential for directed differentiation into CSN. We then employ a multi-component construct with complementary and differentiation-sharpening transcriptional controls (activating &lt;i&gt;Neurog2&lt;/i&gt;, &lt;i&gt;Fezf2&lt;/i&gt;, while antagonizing &lt;i&gt;Olig2&lt;/i&gt; with &lt;i&gt;VP16:Olig2&lt;/i&gt;). We generate corticospinal-like neurons from SOX6+/NG2+ cortical progenitors and find that these neurons differentiate with remarkable fidelity compared with corticospinal neurons in vivo. They possess appropriate morphological, molecular, transcriptomic, and electrophysiological characteristics, without characteristics of the alternate intracortical or other neuronal subtypes. We identify that these critical specifics of differentiation are not reproduced by commonly employed &lt;i&gt;Neurog2&lt;/i&gt;-driven differentiation. Neurons induced by &lt;i&gt;Neurog2&lt;/i&gt; instead exhibit aberrant multi-axon morphology and express molecular hallmarks of alternate cortical projection subtypes, often in mixed form. Together, this developmentally-based directed differentiation from cortical progenitors sets a precedent and foundation for &lt;i&gt;in vitro&lt;/i&gt; mechanistic and therapeutic disease modeling, and toward regenerative neuronal repopulation and circuit repair.</description>
      <author>jeffrey_macklis@harvard.edu (Abdulkadir Ozkan)</author>
      <author>jeffrey_macklis@harvard.edu (A Nazli Basak)</author>
      <author>jeffrey_macklis@harvard.edu (Cameron Sadegh)</author>
      <author>jeffrey_macklis@harvard.edu (Eiman Azim)</author>
      <author>jeffrey_macklis@harvard.edu (Hari K Padmanabhan)</author>
      <author>jeffrey_macklis@harvard.edu (Jeffrey D Macklis)</author>
      <author>jeffrey_macklis@harvard.edu (Priyanka Kumar)</author>
      <author>jeffrey_macklis@harvard.edu (Seth L Shipman)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.100340</guid>
      <category>Neuroscience</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Tue, 27 Jan 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-01-27T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>A titin missense variant drives atrial electrical remodeling and is associated with atrial fibrillation</title>
      <link>https://elifesciences.org/articles/104719</link>
      <description>Rare and common genetic variants contribute to the risk of atrial fibrillation (AF). Although ion channels were among the first AF candidate genes identified, rare loss-of-function variants in structural genes, such as &lt;i&gt;TTN&lt;/i&gt;, have also been implicated in AF pathogenesis, partly through the development of atrial myopathy; however, the underlying mechanisms are poorly understood. While &lt;i&gt;TTN&lt;/i&gt; truncating variants (&lt;i&gt;TTN&lt;/i&gt;tvs) have been causally linked to arrhythmia and cardiomyopathy syndromes, the role of missense variants (mvs) remains unclear. We show that rare &lt;i&gt;TTNmvs&lt;/i&gt; are associated with worse clinical outcomes in a single-center ethnic minority clinical cohort and uncover a pathogenic mechanism by which the T32756I variant drives AF. Modeling the &lt;i&gt;TTN&lt;/i&gt;-T32756I variant using human induced pluripotent stem cell-derived atrial cardiomyocytes (iPSC-aCMs) revealed that the mutant cells display aberrant contractility, increased activity of a cardiac potassium channel (KCNQ1, Kv7.1), and dysregulated calcium homeostasis without compromising the sarcomeric integrity of the atrial cardiomyocytes. We also show that a titin-binding protein, the Four-and-a-Half Lim domains 2 (FHL2), has increased binding with KCNQ1 and its modulatory subunit KCNE1 in the &lt;i&gt;TTN-&lt;/i&gt;T32756I-iPSC-aCMs, enhancing the slow delayed rectifier potassium current (&lt;i&gt;I&lt;/i&gt;&lt;sub&gt;ks&lt;/sub&gt;). Suppression of FHL2 in mutant iPSC-aCMs normalized the &lt;i&gt;I&lt;/i&gt;&lt;sub&gt;ks&lt;/sub&gt;, supporting FHL2 as an &lt;i&gt;I&lt;/i&gt;&lt;sub&gt;ks&lt;/sub&gt; modulator. Our findings demonstrate that a single amino acid substitution in titin not only impairs its function but also remodels ion channels, contributing to AF. These findings underscore the importance of high-throughput screening to assess the pathogenicity of &lt;i&gt;TTN&lt;/i&gt;mvs and establish a mechanistic connection between titin, potassium ion channels, and sarcomeric proteins, which may represent a novel therapeutic target.</description>
      <author>gmmahmud@uic.edu (Abhinaya Baskaran)</author>
      <author>gmmahmud@uic.edu (Arvind Sridhar)</author>
      <author>gmmahmud@uic.edu (Asia Owais)</author>
      <author>gmmahmud@uic.edu (Aylin Ornelas Loredo)</author>
      <author>gmmahmud@uic.edu (Bahaa Al-Azzam)</author>
      <author>gmmahmud@uic.edu (Brandon Chalazan)</author>
      <author>gmmahmud@uic.edu (Dawood Darbar)</author>
      <author>gmmahmud@uic.edu (Faisal A Darbar)</author>
      <author>gmmahmud@uic.edu (Hanna Chen)</author>
      <author>gmmahmud@uic.edu (Jaime DeSantiago)</author>
      <author>gmmahmud@uic.edu (Jalees Rehman)</author>
      <author>gmmahmud@uic.edu (Mahmud Arif Pavel)</author>
      <author>gmmahmud@uic.edu (Michael Hill)</author>
      <author>gmmahmud@uic.edu (Miles Barney)</author>
      <author>gmmahmud@uic.edu (Shashank Sandu)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.104719</guid>
      <category>Medicine</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Thu, 22 Jan 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-01-22T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Identification of a sub-population of synovial mesenchymal stem cells with enhanced treatment efficacy in a rat model of osteoarthritis</title>
      <link>https://elifesciences.org/articles/103332</link>
      <description>Osteoarthritis (OA) is a painful, debilitating disease with no cure or treatments that can predictably stop/reverse its progression. Treatment is particularly difficult since articular cartilage lacks intrinsic repair capacity, despite mesenchymal stem cells (MSCs) being present in the joint with robust chondrogenic potential. While heterogeneity exists among MSC subtypes within human synovium, it remains unclear which populations can regenerate cartilage or impact OA progression. We clonally isolated MSCs from normal and OA patient synovium using indexed flow cytometry, then characterized them through differentiation assays and quantitative proteomics. MSC clones were transplanted into a xenograft rat OA model and evaluated by histology and immunofluorescence. We identified heterogeneity in putative MSCs within and between patient groups and their repair capacity in the rat model. However, traditional cell surface markers could not distinguish these subtypes, highlighting the need for single-cell level understanding. Using unbiased proteomics, we identified CD47 as a novel MSC marker. CD47&lt;sup&gt;Hi&lt;/sup&gt; cells demonstrated robust treatment efficacy in the rat OA model and directly contributed to new articular cartilage formation. Characterizing MSC subtypes is essential for identifying candidates appropriate for clinical investigation and exploiting functional MSCs for cartilage regeneration strategies.</description>
      <author>rkrawetz@ucalgary.ca (Anand O Masson)</author>
      <author>rkrawetz@ucalgary.ca (Antoine Dufour)</author>
      <author>rkrawetz@ucalgary.ca (Asmaa Affan)</author>
      <author>rkrawetz@ucalgary.ca (Catherine Leonard)</author>
      <author>rkrawetz@ucalgary.ca (Daniel Young)</author>
      <author>rkrawetz@ucalgary.ca (James N Powell)</author>
      <author>rkrawetz@ucalgary.ca (Luiz Gustavo Almeida)</author>
      <author>rkrawetz@ucalgary.ca (Nabangshu Das)</author>
      <author>rkrawetz@ucalgary.ca (Nedaa Al-Jezani)</author>
      <author>rkrawetz@ucalgary.ca (Pam Railton)</author>
      <author>rkrawetz@ucalgary.ca (Paul Salo)</author>
      <author>rkrawetz@ucalgary.ca (Roman J Krawetz)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.103332</guid>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Tue, 20 Jan 2026 00:00:00 +0000</pubDate>
      <dc:date>2026-01-20T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>IL-27 limits HSPC differentiation during infection and protects from stem cell exhaustion</title>
      <link>https://elifesciences.org/articles/105876</link>
      <description>Many inflammatory stimuli can induce progenitor cells in the bone marrow to produce increased numbers of myeloid cells as part of the process of emergency myelopoiesis. These events are associated with trained immunity and have long-term impacts on hematopoietic stem and progenitor cell (HSPC) development but can also compromise their function. While many cytokines support emergency myelopoiesis, less is known about the mechanisms that temper these events. When mice that lack the cytokine IL-27 were infected with &lt;i&gt;Toxoplasma gondii&lt;/i&gt;, there was enhanced generation of monocyte progenitors and increased numbers of inflammatory monocytes. In the bone marrow of infected mice, there was increased production of IL-27 that localized with HSPCs, and a survey of cytokine receptor expression highlighted that HSPCs were uniquely poised to respond to IL-27. Furthermore, the use of in vitro differentiation assays and mixed bone marrow chimeras revealed that HSPCs from IL-27-deficient mice are predisposed toward the monocyte lineage. Additional studies highlighted that after infection, loss of the IL-27R resulted in reduced HSPC fitness that manifested as reduced proliferative responses and a decreased ability to reconstitute the hematopoietic system. Thus, the ability of IL-27 to act on HSPC provides a regulatory brake on differentiation to limit monocyte induction and preserve HSPC stemness.</description>
      <author>chunter@vet.upenn.edu (Anthony T Phan)</author>
      <author>chunter@vet.upenn.edu (Booki Min)</author>
      <author>chunter@vet.upenn.edu (Christopher A Hunter)</author>
      <author>chunter@vet.upenn.edu (Daniel L Aldridge)</author>
      <author>chunter@vet.upenn.edu (David A Christian)</author>
      <author>chunter@vet.upenn.edu (Ross Kedl)</author>
      <author>chunter@vet.upenn.edu (Ryan D Pardy)</author>
      <author>chunter@vet.upenn.edu (Zachary Lanzar)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.105876</guid>
      <category>Immunology and Inflammation</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Mon, 15 Dec 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-12-15T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Glycogen engineering improves the starvation resistance of mesenchymal stem cells and their therapeutic efficacy in pulmonary fibrosis</title>
      <link>https://elifesciences.org/articles/106023</link>
      <description>Mesenchymal stem cells (MSCs) are widely used in regenerative medicine, including the treatment of pulmonary fibrosis. However, implanted MSCs disappear within days, constraining therapeutic efficacy, which is largely attributed to nutrient deprivation. In this study, we established glycogen metabolism engineering strategies in mammalian cells. By expressing a functionally optimized glycogen synthase (GYSmut), MSCs could accumulate large amounts of glycogen rapidly as a reserve substance. Glycogen engineering significantly improved the survival of MSCs during starvation both in vitro and in vivo, enhancing cell viability post-implantation and their therapeutic efficacy in pulmonary fibrosis. Glycogen-engineered MSCs may serve as chassis cells for further applications. Our research highlights the importance of glucose metabolism regulation in cell-based therapy and demonstrates the great potential for the metabolic engineering of MSCs and other therapeutic cells.</description>
      <author>wuqiong@mail.tsinghua.edu.cn (Bo Zhang)</author>
      <author>wuqiong@mail.tsinghua.edu.cn (Hanqi Xie)</author>
      <author>wuqiong@mail.tsinghua.edu.cn (Haowei Xu)</author>
      <author>wuqiong@mail.tsinghua.edu.cn (Lei Wang)</author>
      <author>wuqiong@mail.tsinghua.edu.cn (Mamatali Rahman)</author>
      <author>wuqiong@mail.tsinghua.edu.cn (Qiong Wu)</author>
      <author>wuqiong@mail.tsinghua.edu.cn (Shan Cheng)</author>
      <author>wuqiong@mail.tsinghua.edu.cn (Xiaodan Sun)</author>
      <author>wuqiong@mail.tsinghua.edu.cn (Yongyue Xu)</author>
      <author>wuqiong@mail.tsinghua.edu.cn (Zhaoyan Wang)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.106023</guid>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Tue, 09 Dec 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-12-09T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Joint profiling of cell morphology and gene expression during in vitro neurodevelopment</title>
      <link>https://elifesciences.org/articles/102578</link>
      <description>Differentiation of induced pluripotent stem cells (iPSCs) toward neuronal lineages has enabled diverse cellular models of human neurodevelopment and related disorders. Here, we jointly profiled neuronal morphology and gene expression at single-cell resolution across 60,000 iPSC-derived cortical neurons at three developmental time points with Cell Painting (CP) and single-cell RNA-sequencing (scRNA-seq). By modeling the relationship between morphological features and gene expression within our differentiation system, we annotated image-based features with biological functions and showed that while CP resolves broader neuronal classes than scRNA-seq, it complements transcriptomic data by quantifying the biological processes that drive neuronal differentiation over time, such as mitochondrial function and cell cycle. Further, we found that while over 60% of the cells resembled those seen in the fetal brain, 28% represented metabolically abnormal cell states and broader neuronal classes specific to &lt;i&gt;in vitro&lt;/i&gt; cells. We show that iPSC-derived cortical neurons are nonetheless a relevant model for a range of brain-related complex traits, including schizophrenia and bipolar disorder, and that disease heritability can also be captured in the morphological feature space. Finally, we applied CP to iPSC-derived neural progenitors from patients with Kabuki syndrome, revealing morphological signatures of precocious differentiation and altered cell cycling. These results highlight the potential of multi-modal single-cell characterization to reveal complementary and disease-relevant cellular and molecular phenotypes.</description>
      <author>helena.kilpinen@helsinki.fi (Adithi Sundaresh)</author>
      <author>helena.kilpinen@helsinki.fi (Andrea Ganna)</author>
      <author>helena.kilpinen@helsinki.fi (Dimitri Meistermann)</author>
      <author>helena.kilpinen@helsinki.fi (Helena Kilpinen)</author>
      <author>helena.kilpinen@helsinki.fi (Pau Puigdevall Costa)</author>
      <author>helena.kilpinen@helsinki.fi (Riina Lampela)</author>
      <author>helena.kilpinen@helsinki.fi (Rosa Woldegebriel)</author>
      <author>helena.kilpinen@helsinki.fi (Zhiyu Yang)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.102578</guid>
      <category>Genetics and Genomics</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Mon, 01 Dec 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-12-01T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>&lt;i&gt;Smed-pou4-2&lt;/i&gt; regulates mechanosensory neuron regeneration and function in planarians</title>
      <link>https://elifesciences.org/articles/107718</link>
      <description>POU4 homologs are involved in the development of sensory cell types across diverse species, including cnidarians, ascidians, and mammals. Whether these developmental regulators are redeployed during adult tissue maintenance and regeneration remains an open question in regenerative biology. Here, we investigated the role of the &lt;i&gt;Schmidtea mediterranea&lt;/i&gt; BRN3/POU4 homolog, &lt;i&gt;Smed-pou4-2&lt;/i&gt; (&lt;i&gt;pou4-2&lt;/i&gt;), in the regeneration of mechanosensory neurons. We found that &lt;i&gt;pou4-2&lt;/i&gt; is regulated by the SoxB1 homolog &lt;i&gt;soxB1-2&lt;/i&gt; and is expressed in a distinct population of ciliated sensory cells that detect water flow. Transcriptomic analysis of &lt;i&gt;pou4-2&lt;/i&gt;-deficient planarians revealed enrichment for conserved genes associated with human auditory and vestibular function, suggesting that planarian rheosensory neurons share molecular features with mammalian inner ear hair cells. Expression of these conserved genes was significantly reduced following RNAi-mediated knockdown of &lt;i&gt;pou4-2&lt;/i&gt;. To determine whether these transcriptional changes had functional consequences, we assessed the impact of &lt;i&gt;pou4-2&lt;/i&gt; knockdown on sensory function. &lt;i&gt;pou4-2&lt;/i&gt; RNAi resulted in impaired mechanosensation in both uninjured and regenerating planarians. Together with the loss of terminal differentiation markers in mechanosensory neurons, these findings identify &lt;i&gt;Smed-pou4-2&lt;/i&gt; as a key regulator of mechanosensory neuron identity in planarians and support the idea that conserved sensory specification programs are redeployed during adult tissue regeneration.</description>
      <author>rzayas@sdsu.edu (Kelly G Ross)</author>
      <author>rzayas@sdsu.edu (Mohammad A Auwal)</author>
      <author>rzayas@sdsu.edu (Ricardo M Zayas)</author>
      <author>rzayas@sdsu.edu (Robert W Zeller)</author>
      <author>rzayas@sdsu.edu (Roman Sasik)</author>
      <author>rzayas@sdsu.edu (Ryan A McCubbin)</author>
      <author>rzayas@sdsu.edu (Sarai Alvarez Zepeda)</author>
      <author>rzayas@sdsu.edu (Shengzhou Wang)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107718</guid>
      <category>Developmental Biology</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Tue, 18 Nov 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-11-18T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Changes in neural progenitor lineage composition during astrocytic differentiation of human iPSCs</title>
      <link>https://elifesciences.org/articles/96423</link>
      <description>The regional specificity of stem cell-derived astrocytes is believed to be an important prerequisite for their application in disease modelling and cell-based therapies. Due to the lack of subtype-defining markers for astrocytes in different regions of the brain, the regional identity of in vitro-derived astrocytes is often declared by the dominant positional characteristics of their antecedent neural progenitors, patterned to a fate of interest, with the assumption that the positional trait is preserved by the derived astrocytes via linear descent. Using a human induced pluripotent stem cell line designed for tracing derivatives of LMX1A&lt;sup&gt;+&lt;/sup&gt; cells combined with a ventral midbrain induction paradigm, we show that astrocytes originating from LMX1A&lt;sup&gt;+&lt;/sup&gt; progenitors can only be generated if these progenitors are purified prior to the astrocyte differentiation process, or their progenies are gradually lost to progenies of LMX1A&lt;sup&gt;-&lt;/sup&gt; progenitors. This finding indicates that the lineage composition of iPSC-derived astrocytes may not accurately recapitulate the founder progenitor population. Using deep single-cell RNA sequencing, we identified distinct transcriptomic signatures in astrocytes derived from the LMX1A&lt;sup&gt;+&lt;/sup&gt; progenitor cells. Our study highlights the need for rigorous characterization of pluripotent stem cell-derived regional astrocytes and provides a resource for assessing LMX1A&lt;sup&gt;+&lt;/sup&gt; ventral midbrain progenitor-derived human astrocytes.</description>
      <author>webberc4@cardiff.ac.uk (Caleb Webber)</author>
      <author>webberc4@cardiff.ac.uk (Frank Wessely)</author>
      <author>webberc4@cardiff.ac.uk (Jimena Monzón-Sandoval)</author>
      <author>webberc4@cardiff.ac.uk (Lucia Fernandez Cardo)</author>
      <author>webberc4@cardiff.ac.uk (Meng Li)</author>
      <author>webberc4@cardiff.ac.uk (Michal Rokicki)</author>
      <author>webberc4@cardiff.ac.uk (Viola Volpato)</author>
      <author>webberc4@cardiff.ac.uk (Zongze Li)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.96423</guid>
      <category>Developmental Biology</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Tue, 28 Oct 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-10-28T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Stabilisation of HIF signalling in the mouse epicardium extends embryonic potential and neonatal heart regeneration</title>
      <link>https://elifesciences.org/articles/107419</link>
      <description>In humans, new-born infants can regenerate their heart during early life. This is modelled in the mouse, where regenerative capacity is maintained for the first week after birth but lost thereafter. Reactivation of this process holds great therapeutic potential; however, the molecular pathways that might be targeted to extend neonatal regeneration remain elusive. Here, we explored a role for hypoxia and HIF signalling on the regulation of epicardial activity in the developing mouse heart and in modulating the response to injury. Hypoxic regions were found in the epicardium from mid-gestation, associating with HIF-1α and HIF-2α, and expression of the epicardial master regulator Wilms’ tumour 1 (WT1). Epicardial deletion of &lt;i&gt;Hif1α&lt;/i&gt; reduced WT1 levels, leading to impaired coronary vasculature. Targeting of the HIF degradation enzyme PHD, through pharmacological inhibition with a clinically approved drug or epicardial-specific genetic deletion of &lt;i&gt;Egln1&lt;/i&gt;, stabilised HIF and promoted WT1 activity ex vivo. Finally, a combination of genetic and pharmacological stabilisation of HIF during neonatal heart injury led to prolonged epicardial activation, preservation of myocardium, augmented infarct resolution and preserved function beyond the 7-day regenerative window. These findings suggest modulation of HIF signalling extends epicardial activation to maintain myocardial survival beyond the neonatal regenerative window and may represent a viable strategy for treating ischaemic heart disease.</description>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Adam B Lokman)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Carla De Villiers)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Carolina Roque Silva)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Carolyn A Carr)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Chris W Pugh)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Daniela Pezzolla)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (David Robert Mole)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Eleanor L Price)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Elisabetta Gamen)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Joaquim Miguel Vieira)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Judith Sayers)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Mala Gunadasa-Rohling)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Maria-Alexa Cosma)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Paul R Riley)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Rafik Salama)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Robin P Choudhury)</author>
      <author>joaquim.nunes_vieira@kcl.ac.uk (Tammie Bishop)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107419</guid>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Wed, 22 Oct 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-10-22T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Chromatin activity of IκBα mediates the exit from naïve pluripotency</title>
      <link>https://elifesciences.org/articles/102784</link>
      <description>Maintenance of pluripotency is a multifactorial process in which NF-κB is a negative regulator. Our previous work identified a chromatin role for IκBα, the master regulator of NF-κB signaling, that is critical for the proper regulation of various tissue stem cells. Here, we found that IκBα accumulates specifically in the chromatin fraction of mouse pluripotent stem cells. IκBα depletion does not affect NF-kB-dependent transcription, but causes a profound epigenetic rewiring in pluripotent stem cells, including alterations in H3K27me3, a histone mark catalyzed by Polycomb repression complex 2. Chromatin changes induced by IκBα depletion affect a subset of pluripotency genes and are associated with altered gene transcription. At the cellular level, IκBα-deficient embryonic stem cells are arrested in a naive pluripotency state when cultured in serum/LIF conditions and fail to exit pluripotency under differentiation conditions. By constructing separation-of-function mutants, we show that the effects of IκBα in regulating stem cell pluripotency are NF-κB-independent, but mainly rely on its chromatin-related function. Taken together, our results reveal a novel mechanism by which IκBα participates in the regulation of the pluripotent state of mouse embryonic stem cells and shed light on the interplay between inflammatory signals and the regulation of pluripotency.</description>
      <author>lespinosa@researchmar.net (Alberto Villanueva)</author>
      <author>lespinosa@researchmar.net (Anna Bigas)</author>
      <author>lespinosa@researchmar.net (Arnau Iglesias)</author>
      <author>lespinosa@researchmar.net (August Vidal)</author>
      <author>lespinosa@researchmar.net (Bernhard Payer)</author>
      <author>lespinosa@researchmar.net (Carlos A Garcia-Prieto)</author>
      <author>lespinosa@researchmar.net (Cecilia Ballare)</author>
      <author>lespinosa@researchmar.net (Clara Bueno)</author>
      <author>lespinosa@researchmar.net (Damiana Alvarez)</author>
      <author>lespinosa@researchmar.net (Daniel Alvarez-Villanueva)</author>
      <author>lespinosa@researchmar.net (Gregoire Stik)</author>
      <author>lespinosa@researchmar.net (Joan Bertran)</author>
      <author>lespinosa@researchmar.net (Lluis Espinosa)</author>
      <author>lespinosa@researchmar.net (Luciano Di Croce)</author>
      <author>lespinosa@researchmar.net (Luis G Palma)</author>
      <author>lespinosa@researchmar.net (Manel Esteller)</author>
      <author>lespinosa@researchmar.net (Maria Maqueda)</author>
      <author>lespinosa@researchmar.net (Mercedes Barrero)</author>
      <author>lespinosa@researchmar.net (Pablo Menendez)</author>
      <author>lespinosa@researchmar.net (Virginia Rodriguez-Cortez)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.102784</guid>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Wed, 22 Oct 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-10-22T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Spatial and longitudinal tracking of enhancer-AAV vectors that target transgene expression to injured mouse myocardium</title>
      <link>https://elifesciences.org/articles/107148</link>
      <description>Tissue regeneration enhancer elements (TREEs) direct expression of target genes in injured and regenerating tissues. Additionally, TREEs of zebrafish origin were shown to direct expression of transgenes in border zone regions after cardiac injury when packaged into recombinant adeno-associated viral (AAV) vectors and introduced into mice. Future implementation of TREEs into AAV-based vectors as research tools and potential gene therapy modalities requires a deeper understanding of expression dynamics and potential off-target effects. Here, we applied in vivo bioluminescent imaging to mice systemically injected with AAV vectors containing different combinations of capsids, enhancers, and timing of delivery. Longitudinal tracking of expression directed by different TREEs revealed distinct amplitudes and durations of reporter gene expression in the injured heart. The liver-de-targeted AAV capsid, AAV.cc84, could deliver TREEs either pre- or post-cardiac injury to negate off-target expression in the liver while maintaining transduction in the heart. By screening AAV9-based capsid libraries dosed systemically in mice post-cardiac injury, we discovered a new capsid variant, AAV.IR41, with enhanced transduction in cardiac injuries and with elevated transduction of TREE-driven transgenes versus conventional AAV9 vectors. In vivo bioluminescence imaging offers insights into how enhancers and engineered capsids can be implemented to modulate spatiotemporal transgene expression for targeted therapies.</description>
      <author>aravind.asokan@duke.edu (Alan Rosales)</author>
      <author>aravind.asokan@duke.edu (Aravind Asokan)</author>
      <author>aravind.asokan@duke.edu (David W Wolfson)</author>
      <author>aravind.asokan@duke.edu (Garth W Devlin)</author>
      <author>aravind.asokan@duke.edu (Joshua A Hull)</author>
      <author>aravind.asokan@duke.edu (Kelsey A Oonk)</author>
      <author>aravind.asokan@duke.edu (Kenneth D Poss)</author>
      <author>aravind.asokan@duke.edu (Mourya D Jayaram)</author>
      <author>aravind.asokan@duke.edu (Nenad Bursac)</author>
      <author>aravind.asokan@duke.edu (Trevor J Gonzalez)</author>
      <author>aravind.asokan@duke.edu (Valentina Cigliola)</author>
      <author>aravind.asokan@duke.edu (Yongwu Li)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107148</guid>
      <category>Developmental Biology</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Fri, 12 Sep 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-09-12T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Endothelin B receptor inhibition rescues aging-dependent neuronal regenerative decline</title>
      <link>https://elifesciences.org/articles/100217</link>
      <description>Peripheral sensory neurons regenerate their axons after injury to regain function, but this ability declines with age. The mechanisms behind this decline are not fully understood. While excessive production of endothelin 1 (ET-1), a potent vasoconstrictor, is linked to many diseases that increase with age, the role of ET-1 and its receptors in axon regeneration is unknown. Using single-cell RNA sequencing, we show that satellite glial cells (SGCs), which completely envelop the sensory neuron soma residing in the dorsal root ganglia (DRG), express the endothelin B receptor (ETBR), while ET-1 is expressed by endothelial cells. Inhibition of ETBR ex vivo in DRG explant cultures improves axon growth in both adult and aged conditions. In vivo, treatment with the FDA-approved compound, Bosentan, improves axon regeneration and reverses the age-dependent decrease in axonal regenerative capacity. Single-nuclei RNA sequencing and electron microscopy analyses reveal a decreased abundance of SGCs in aged mice compared to adult mice. Additionally, the decreased expression of connexin 43 (Cx43) in SGCs in aged mice after nerve injury is partially rescued by Bosentan treatment. These results reveal that inhibiting ETBR function enhances axon regeneration and rescues the age-dependent decrease in axonal regenerative capacity, providing a potential avenue for future therapies.</description>
      <author>cavalli@wustl.edu (Cedric G Geoffroy)</author>
      <author>cavalli@wustl.edu (Irshad Ansari)</author>
      <author>cavalli@wustl.edu (Michael B Thomsen)</author>
      <author>cavalli@wustl.edu (Oshri Avraham)</author>
      <author>cavalli@wustl.edu (Rui Feng)</author>
      <author>cavalli@wustl.edu (Sarah F Rosen)</author>
      <author>cavalli@wustl.edu (Sebastian John)</author>
      <author>cavalli@wustl.edu (Valeria Cavalli)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.100217</guid>
      <category>Neuroscience</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Tue, 09 Sep 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-09-09T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Alteration of long- and short-term hematopoietic stem cell ratio causes myeloid-biased hematopoiesis</title>
      <link>https://elifesciences.org/articles/95880</link>
      <description>Myeloid-biased hematopoiesis is a well-known age-related alteration. Several possibilities, including myeloid-biased hematopoietic stem cell (HSC) clones, may explain this. However, the precise mechanisms remain controversial. Utilizing the Hoxb5 reporter system to prospectively isolate long-term HSCs (LT-HSCs) and short-term HSCs (ST-HSCs), we found that young and aged LT-HSCs co-transplanted into the same recipients demonstrated nearly equivalent myeloid lineage output, contrary to the theory of myeloid-biased HSC clones. Transcriptomics indicated no significant myeloid gene enrichment in aged LT-HSCs compared to their young counterparts. Instead, transplanting reconstituted young HSCs with the ratio of LT/ST-HSCs seen in aged mice can significantly skew the lineage output to myeloid cells. In addition, while the niche environment in the bone marrow minimally affects myeloid-biased hematopoiesis, aged thymi and spleens substantially hinder lymphoid hematopoiesis, resulting in further myeloid domination. Thus, we demonstrate that myeloid-biased hematopoiesis in aged mice originates due to alteration of the ratio between LT-HSCs and ST-HSCs rather than in heterogeneous HSC clones with various cell fates.</description>
      <author>miya75@med.kobe-u.ac.jp (Akifumi Takaori-Kondo)</author>
      <author>miya75@med.kobe-u.ac.jp (Akiomi Nagasaka)</author>
      <author>miya75@med.kobe-u.ac.jp (Katsuyuki Nishi)</author>
      <author>miya75@med.kobe-u.ac.jp (Kay Sadaoka)</author>
      <author>miya75@med.kobe-u.ac.jp (Kevin Shuolong Kao)</author>
      <author>miya75@med.kobe-u.ac.jp (Masahide Asano)</author>
      <author>miya75@med.kobe-u.ac.jp (Masanori Miyanishi)</author>
      <author>miya75@med.kobe-u.ac.jp (Nobuyuki Yamamoto)</author>
      <author>miya75@med.kobe-u.ac.jp (Taro Sakamaki)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.95880</guid>
      <category>Developmental Biology</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Wed, 27 Aug 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-08-27T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Stochastic cell-intrinsic stem cell decisions control colony growth in planarians</title>
      <link>https://elifesciences.org/articles/100885</link>
      <description>Stem cells contribute to organismal homeostasis by balancing division, self-renewal, and differentiation. Elucidating the strategies by which stem cells achieve this balance is critical for understanding homeostasis and for addressing pathogenesis associated with the disruption of this balance (e.g. cancer). Planarians, highly regenerative flatworms, use pluripotent stem cells called neoblasts to maintain and regrow organs. A single neoblast can rescue an entire animal depleted from stem cells and regenerate all cell lineages. How neoblast differentiation and clonal expansion are governed to produce all the required cell types remains unclear. Here, we integrated experimental and computational approaches to develop a quantitative model revealing basic principles of clonal growth of individual neoblasts. By experimentally suppressing differentiation to major lineages, we elucidated the interplay between colony growth and lineage decisions. Our findings suggest that neoblasts select their progenitor lineage based on a cell-intrinsic fate distribution. Arresting differentiation into specific lineages disrupts neoblast proliferative capacity without inducing compensatory expression of other lineages. Our analysis of neoblast colonies is consistent with a cell-intrinsic decision model that can operate without memory or communication between neoblasts. This simple cell fate decision process breaks down in homeostasis, likely because of the activity of feedback mechanisms. Our findings uncover essential principles of stem cell regulation in planarians, which are distinct from those observed in many vertebrate models. These mechanisms enable robust production of diverse cell types and facilitate regeneration of missing tissues.</description>
      <author>owurtzel@tauex.tau.ac.il (Omri Wurtzel)</author>
      <author>owurtzel@tauex.tau.ac.il (Prakash Varkey Cherian)</author>
      <author>owurtzel@tauex.tau.ac.il (Simon Dobler)</author>
      <author>owurtzel@tauex.tau.ac.il (Tamar Frankovits)</author>
      <author>owurtzel@tauex.tau.ac.il (Yarden Yesharim)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.100885</guid>
      <category>Developmental Biology</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Wed, 23 Jul 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-07-23T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>PRDM16 functions as a co-repressor in the BMP pathway to suppress neural stem cell proliferation</title>
      <link>https://elifesciences.org/articles/104076</link>
      <description>BMP signaling acts as an instructive cue in various developmental processes such as tissue patterning, stem cell proliferation, and differentiation. However, it is not fully understood how this signaling pathway generates different cell-specific outputs. Here, we have identified PRDM16 as a key co-factor for BMP signaling in the mouse brain. PRDM16 contributes to a repressive role of BMP signaling on neural stem cell (NSC) proliferation. We demonstrate that PRDM16 regulates the genomic distribution of BMP pathway transcription factors, the SMAD4/pSMAD complex, preventing the activation of cell proliferation genes. When &lt;i&gt;Prdm16&lt;/i&gt; is lost, the SMAD complex relocates to nearby genomic regions, leading to abnormal upregulation of BMP target genes. This function of PRDM16 is also required for the specification of choroid plexus (ChP) epithelial cells. Through a single-cell resolution fluorescent in situ approach, we have observed that genes co-repressed by SMAD and PRDM16, such as &lt;i&gt;Wnt7b&lt;/i&gt; and several cell cycle regulators, become overexpressed in &lt;i&gt;Prdm16&lt;/i&gt; mutant ChP. Our findings elucidate a mechanism through which SMAD4 and pSMAD1/5/8 repress gene expression. Moreover, our study suggests a regulatory circuit composed of BMP and Wnt signaling, along with PRDM16, in controlling stem cell behaviors.</description>
      <author>jiayu.wen@anu.edu.au (Jiayu Wen)</author>
      <author>jiayu.wen@anu.edu.au (Li He)</author>
      <author>jiayu.wen@anu.edu.au (Qi Dai)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.104076</guid>
      <category>Developmental Biology</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Mon, 14 Jul 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-07-14T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Aiming for spatial and temporal control of gene expression</title>
      <link>https://elifesciences.org/articles/107945</link>
      <description>Bioluminescent imaging is helping researchers better understand the effectiveness of tissue regeneration enhancers delivered to injured heart tissue by different adeno-associated virus vectors.</description>
      <author>clien@chla.usc.edu (Ching-Ling Lien)</author>
      <author>clien@chla.usc.edu (Stanislao Igor Travisano)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.107945</guid>
      <category>Developmental Biology</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Thu, 10 Jul 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-07-10T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>CRISPR-edited DPSCs constitutively expressing BDNF enhance dentin regeneration in injured teeth</title>
      <link>https://elifesciences.org/articles/105153</link>
      <description>Dental caries, a prevalent global health issue, results from complex bacterial interactions. In response to harmful stimuli, a desirable outcome for the tooth is the formation of tertiary dentin, a protective reparative process that generates new hard tissue. This reparative dentinogenesis is associated with significant inflammation, which triggers the recruitment and differentiation of dental pulp stem cells (DPSCs). Previously, we have demonstrated that brain-derived neurotrophic factor (BDNF) and its receptor tropomyosin receptor kinase B (TrkB), key mediators of neural functions, are activated during the DPSC-mediated dentin regeneration process. In this study, we further define the role of inflammation in this process and apply stem cell engineering to enhance dentin regeneration in injured teeth. Our data show that TrkB expression and activation in DPSCs rapidly increase during odontogenic differentiation, further amplified by inflammatory inducers and mediators such as tumor necrosis factor alpha (TNFα), lymphotoxin-alpha, and lipopolysaccharide. An in vivo dentin formation assessment was conducted using a mouse pulp-capping/caries model, where Clustered Regularly Interspaced Short Palindromic Repeats-engineered DPSCs overexpressing BDNF were transplanted into inflamed pulp tissue. This transplantation significantly enhanced dentin regeneration in injured teeth. To further explore potential downstream pathways, we conducted transcriptomic profiling of TNFα-treated DPSCs, both with and without TrkB antagonist cyclotraxin-B. The results revealed significant changes in gene expression related to immune response, cytokine signaling, and extracellular matrix interactions. Taken together, our study advances our understanding of the role of BDNF in dental tissue engineering using DPSCs and identifies potential therapeutic avenues for improving dental tissue repair and regeneration strategies.</description>
      <author>chungsh@uic.edu (Atsawasuwan Phimon)</author>
      <author>chungsh@uic.edu (Ji Hyun Kim)</author>
      <author>chungsh@uic.edu (Muhammad Irfan)</author>
      <author>chungsh@uic.edu (Seung Chung)</author>
      <author>chungsh@uic.edu (Sreelekshmi Sreekumar)</author>
      <author>chungsh@uic.edu (Stephanie Kim)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.105153</guid>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Wed, 09 Jul 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-07-09T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma</title>
      <link>https://elifesciences.org/articles/103256</link>
      <description>Trabecular meshwork (TM) cell therapy has been proposed as a next-generation treatment for elevated intraocular pressure (IOP) in glaucoma, the most common cause of irreversible blindness. Using a magnetic cell steering technique with excellent efficiency and tissue-specific targeting, we delivered two types of cells into a mouse model of glaucoma: either human adipose-derived mesenchymal stem cells (hAMSCs) or induced pluripotent cell derivatives (iPSC-TM cells). We observed a 4.5 [3.1, 6.0] mmHg or 27% reduction in intraocular pressure (IOP) for 9 months after a single dose of only 1500 magnetically steered hAMSCs, explained by increased outflow through the conventional pathway and associated with a higher TM cellularity. iPSC-TM cells were also effective, but less so, showing only a 1.9 [0.4, 3.3] mmHg or 13% IOP reduction and increased risk of tumorigenicity. In both cases, injected cells remained detectable in the iridocorneal angle 3 weeks post-transplantation. Based on the locations of the delivered cells, the mechanism of IOP lowering is most likely paracrine signaling. We conclude that magnetically steered hAMSC cell therapy has potential for long-term treatment of ocular hypertension in glaucoma.</description>
      <author>ross.ethier@bme.gatech.edu (Anamik Jhunjhunwala)</author>
      <author>ross.ethier@bme.gatech.edu (A Thomas Read)</author>
      <author>ross.ethier@bme.gatech.edu (Babak N Safa)</author>
      <author>ross.ethier@bme.gatech.edu (C Ross Ethier)</author>
      <author>ross.ethier@bme.gatech.edu (Guorong Li)</author>
      <author>ross.ethier@bme.gatech.edu (Hans E Grossniklaus)</author>
      <author>ross.ethier@bme.gatech.edu (Jessica Chan)</author>
      <author>ross.ethier@bme.gatech.edu (Lin Cheng)</author>
      <author>ross.ethier@bme.gatech.edu (Markus H Kuehn)</author>
      <author>ross.ethier@bme.gatech.edu (M Reza Bahranifard)</author>
      <author>ross.ethier@bme.gatech.edu (Seyed Mohammad Siadat)</author>
      <author>ross.ethier@bme.gatech.edu (Stanislav Y Emelianov)</author>
      <author>ross.ethier@bme.gatech.edu (W Daniel Stamer)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.103256</guid>
      <category>Medicine</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Mon, 07 Jul 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-07-07T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>PI3Kα inhibition blocks osteochondroprogenitor specification and the hyper-inflammatory response to prevent heterotopic ossification</title>
      <link>https://elifesciences.org/articles/91779</link>
      <description>Heterotopic ossification (HO) occurs following mechanical trauma and burns, or congenitally in patients suffering from fibrodysplasia ossificans progressiva (FOP). Recently, we demonstrated that inhibitors of phosphatidylinositol 3-kinase alpha (PI3Kα) may be a useful therapy for patients undergoing HO. In this study, using the already marketed BYL719/Alpelisib/Piqray drug, we have further confirmed these results, detailed the underlying mechanisms of action, and optimized the timing of the administration of BYL719. We found that BYL719 effectively prevents HO even when administered up to 3–7 days after injury. We demonstrate in cell cultures and in a mouse model of HO that the major actions of BYL719 are on-target effects through the inhibition of PI3Kα, without directly affecting ACVR1 or FOP-inducing ACVR1&lt;sup&gt;R206H&lt;/sup&gt; kinase activities. In vivo, we found that a lack of PI3Kα in progenitors at injury sites is sufficient to prevent HO. Moreover, time course assays in HO lesions demonstrate that BYL719 not only blocks osteochondroprogenitor specification but also reduces the inflammatory response. BYL719 inhibits the migration, proliferation, and expression of pro-inflammatory cytokines in monocytes and mast cells, suggesting that BYL719 hampers the hyper-inflammatory status of HO lesions. Altogether, these results highlight the potential of PI3Kα inhibition as a safe and effective therapeutic strategy for HO.</description>
      <author>fventura@ub.edu (Alexandre Deber)</author>
      <author>fventura@ub.edu (Carolina Pimenta-Lope)</author>
      <author>fventura@ub.edu (Francesc Ventura)</author>
      <author>fventura@ub.edu (Gonzalo Sánchez-Duffhues)</author>
      <author>fventura@ub.edu (José Antonio Valer)</author>
      <author>fventura@ub.edu (Jose Luis Rosa)</author>
      <author>fventura@ub.edu (Marie-José Goumans)</author>
      <author>fventura@ub.edu (Marius Wits)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.91779</guid>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Tue, 17 Jun 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-06-17T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Human CD29+/CD56+ myogenic progenitors display tenogenic differentiation potential and facilitate tendon regeneration</title>
      <link>https://elifesciences.org/articles/98636</link>
      <description>Tendon injury occurs at high frequency and is difficult to repair. Identification of human stem cells being able to regenerate tendon will greatly facilitate the development of regenerative medicine for tendon injury. Genetic and functional analyses identify human CD29+/CD56+ myogenic progenitors with tenogenic differentiation potential in vitro and in vivo. Transplantation of human CD29+/CD56+ myogenic progenitors contributes to injured tendon repair and thus improves locomotor function. Interestingly, the tendon differentiation potential in mouse muscle stem cells is minimal and the higher TGFβ signaling level may be the key for the distinct feature of human CD29+/CD56+ myogenic progenitors. The discovery of bi-potential CD29+/CD56+ myogenic progenitors highlights their potential as a novel adult stem cell source for tendon regeneration.</description>
      <author>wjyang@sibcb.ac.cn (Hao Zhou)</author>
      <author>wjyang@sibcb.ac.cn (Jianhua Wang)</author>
      <author>wjyang@sibcb.ac.cn (Lili Han)</author>
      <author>wjyang@sibcb.ac.cn (Minghui Wang)</author>
      <author>wjyang@sibcb.ac.cn (Ping Hu)</author>
      <author>wjyang@sibcb.ac.cn (Shenao Zhou)</author>
      <author>wjyang@sibcb.ac.cn (Sheng Li)</author>
      <author>wjyang@sibcb.ac.cn (Siyuan Zhu)</author>
      <author>wjyang@sibcb.ac.cn (Wenjun Yang)</author>
      <author>wjyang@sibcb.ac.cn (Xiexiang Shao)</author>
      <author>wjyang@sibcb.ac.cn (Xin Fu)</author>
      <author>wjyang@sibcb.ac.cn (Xingzuan Lin)</author>
      <author>wjyang@sibcb.ac.cn (Zhanghua Li)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.98636</guid>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Mon, 19 May 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-05-19T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Simultaneous cyclin D1 overexpression and p27&lt;sup&gt;kip1&lt;/sup&gt; knockdown enable robust Müller glia cell cycle reactivation in uninjured mouse retina</title>
      <link>https://elifesciences.org/articles/100904</link>
      <description>Harnessing the regenerative potential of endogenous stem cells to restore lost neurons is a promising strategy for treating neurodegenerative disorders. Müller glia (MG), the primary glial cell type in the retina, exhibit extraordinary regenerative abilities in zebrafish, proliferating and differentiating into neurons post-injury. However, the regenerative potential of mouse MG is limited by their inherent inability to re-enter the cell cycle, constrained by high levels of the cell cycle inhibitor p27&lt;sup&gt;Kip1&lt;/sup&gt; and low levels of cyclin D1. Here, we report a method to drive robust MG proliferation by adeno-associated virus (AAV)-mediated cyclin D1 overexpression and p27&lt;sup&gt;Kip1&lt;/sup&gt; knockdown. MG proliferation induced by this dual targeting vector was self-limiting, as MG re-entered cell cycle only once. As shown by single-cell RNA-sequencing, cell cycle reactivation led to suppression of interferon signaling, activation of reactive gliosis, and downregulation of glial genes in MG. Over time, the majority of the MG daughter cells retained the glial fate, resulting in an expanded MG pool. Interestingly, about 1% MG daughter cells expressed markers for retinal interneurons, suggesting latent neurogenic potential in a small MG subset. By establishing a safe, controlled method to promote MG proliferation in vivo while preserving retinal integrity, this work provides a valuable tool for combinatorial therapies integrating neurogenic stimuli to promote neuron regeneration.</description>
      <author>wenjun.xiong@cityu.edu.hk (Baoshan Liao)</author>
      <author>wenjun.xiong@cityu.edu.hk (Jan Keung)</author>
      <author>wenjun.xiong@cityu.edu.hk (Julia Ying)</author>
      <author>wenjun.xiong@cityu.edu.hk (Virpi Ahola)</author>
      <author>wenjun.xiong@cityu.edu.hk (Wenjun Xiong)</author>
      <author>wenjun.xiong@cityu.edu.hk (Zhifei Wu)</author>
      <author>wenjun.xiong@cityu.edu.hk (Zongli Zheng)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.100904</guid>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Thu, 03 Apr 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-04-03T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines</title>
      <link>https://elifesciences.org/articles/96941</link>
      <description>Tissue engineering strategies predominantly rely on the production of living substitutes, whereby implanted cells actively participate in the regenerative process. Beyond cost and delayed graft availability, the patient-specific performance of engineered tissues poses serious concerns on their clinical translation ability. A more exciting paradigm consists in exploiting cell-laid, engineered extracellular matrices (eECMs), which can be used as off-the-shelf materials. Here, the regenerative capacity solely relies on the preservation of the eECM structure and embedded signals to instruct an endogenous repair. We recently described the possibility to exploit custom human stem cell lines for eECM manufacturing. In addition to the conferred standardization, the availability of such cell lines opened avenues for the design of tailored eECMs by applying dedicated genetic tools. In this study, we demonstrated the exploitation of CRISPR/Cas9 as a high precision system for editing the composition and function of eECMs. Human mesenchymal stromal/stem cell (hMSC) lines were modified to knock out vascular endothelial growth factor (VEGF) and Runt-related transcription factor 2 (RUNX2) and assessed for their capacity to generate osteoinductive cartilage matrices. We report the successful editing of hMSCs, subsequently leading to targeted VEGF and RUNX2-knockout cartilage eECMs. Despite the absence of VEGF, eECMs retained full capacity to instruct ectopic endochondral ossification. Conversely, RUNX2-edited eECMs exhibited impaired hypertrophy, reduced ectopic ossification, and superior cartilage repair in a rat osteochondral defect. In summary, our approach can be harnessed to identify the necessary eECM factors driving endogenous repair. Our work paves the road toward the compositional eECMs editing and their exploitation in broad regenerative contexts.</description>
      <author>paul.bourgine@med.lu.se (Agatheeswaran Subramaniam)</author>
      <author>paul.bourgine@med.lu.se (Alejandro Garcia Garcia)</author>
      <author>paul.bourgine@med.lu.se (Bai Yiguang)</author>
      <author>paul.bourgine@med.lu.se (David Hidalgo Gil)</author>
      <author>paul.bourgine@med.lu.se (Deepak Bushan Raina)</author>
      <author>paul.bourgine@med.lu.se (Dimitra Zacharaki)</author>
      <author>paul.bourgine@med.lu.se (Karin Linderfalk)</author>
      <author>paul.bourgine@med.lu.se (Ludvig Nilsén Falck)</author>
      <author>paul.bourgine@med.lu.se (Paul E Bourgine)</author>
      <author>paul.bourgine@med.lu.se (Sofie Mohlin)</author>
      <author>paul.bourgine@med.lu.se (Sonia Ferveur)</author>
      <author>paul.bourgine@med.lu.se (Steven J Dupard)</author>
      <author>paul.bourgine@med.lu.se (Sujeethkumar Prithiviraj)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.96941</guid>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Fri, 28 Mar 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-03-28T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Single-cell RNA sequencing of the holothurian regenerating intestine reveals the pluripotency of the coelomic epithelium</title>
      <link>https://elifesciences.org/articles/100796</link>
      <description>In holothurians, the regenerative process following evisceration involves the development of a ‘rudiment’ or ‘anlage’ at the injured end of the mesentery. This regenerating anlage plays a pivotal role in the formation of a new intestine. Despite its significance, our understanding of the molecular characteristics inherent to the constituent cells of this structure has remained limited. To address this gap, we employed state-of-the-art scRNA-seq and hybridization chain reaction fluorescent in situ hybridization analyses to discern the distinct cellular populations associated with the regeneration anlage. Through this approach, we successfully identified 13 distinct cell clusters. Among these, two clusters exhibit characteristics consistent with putative mesenchymal cells, while another four show features akin to coelomocyte cell populations. The remaining seven cell clusters collectively form a large group encompassing the coelomic epithelium of the regenerating anlage and mesentery. Within this large group of clusters, we recognized previously documented cell populations such as muscle precursors, neuroepithelial cells, and actively proliferating cells. Strikingly, our analysis provides data for identifying at least four other cellular populations that we define as the precursor cells of the growing anlage. Consequently, our findings strengthen the hypothesis that the coelomic epithelium of the anlage is a pluripotent tissue that gives rise to diverse cell types of the regenerating intestinal organ. Moreover, our results provide the initial view into the transcriptomic analysis of cell populations responsible for the amazing regenerative capabilities of echinoderms.</description>
      <author>jegarcia@hpcf.upr.edu (Alejandra Beltran-Rivera)</author>
      <author>jegarcia@hpcf.upr.edu (Griselle Valentín-Tirado)</author>
      <author>jegarcia@hpcf.upr.edu (José E Garcia-Arraras)</author>
      <author>jegarcia@hpcf.upr.edu (Joshua G Medina-Feliciano)</author>
      <author>jegarcia@hpcf.upr.edu (Kiara Luna-Martínez)</author>
      <author>jegarcia@hpcf.upr.edu (Yamil Miranda-Negrón)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.100796</guid>
      <category>Developmental Biology</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Thu, 20 Mar 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-03-20T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>GATA6 regulates WNT and BMP programs to pattern precardiac mesoderm during the earliest stages of human cardiogenesis</title>
      <link>https://elifesciences.org/articles/100797</link>
      <description>Haploinsufficiency for &lt;i&gt;GATA6&lt;/i&gt; is associated with congenital heart disease (CHD) with variable comorbidity of pancreatic or diaphragm defects, although the etiology of disease is not well understood. Here, we used cardiac directed differentiation from human embryonic stem cells (hESCs) as a platform to study GATA6 function during early cardiogenesis. GATA6 loss-of-function hESCs had a profound impairment in cardiac progenitor cell (CPC) specification and cardiomyocyte (CM) generation due to early defects during the mesendoderm and lateral mesoderm patterning stages. Profiling by RNA-seq and CUT&amp;amp;RUN identified genes of the WNT and BMP programs regulated by GATA6 during early mesoderm patterning. Furthermore, interactome analysis detected GATA6 binding with developmental transcription factors and chromatin remodelers, suggesting cooperative regulation of cardiac lineage gene accessibility. We show that modulating WNT and BMP inputs during the first 48 hr of cardiac differentiation is sufficient to partially rescue CPC and CM defects in &lt;i&gt;GATA6&lt;/i&gt; heterozygous and homozygous mutant hESCs. This study provides evidence of the regulatory functions for GATA6 directing human precardiac mesoderm patterning during the earliest stages of cardiogenesis to further our understanding of haploinsufficiency causing CHD and the co-occurrence of cardiac and other organ defects caused by human &lt;i&gt;GATA6&lt;/i&gt; mutations.</description>
      <author>tre2003@med.cornell.edu (Danwei Huangfu)</author>
      <author>tre2003@med.cornell.edu (Dapeng Yang)</author>
      <author>tre2003@med.cornell.edu (Ellen Yang)</author>
      <author>tre2003@med.cornell.edu (Joseph A Bisson)</author>
      <author>tre2003@med.cornell.edu (Kelly M Banks)</author>
      <author>tre2003@med.cornell.edu (Kihyun Lee)</author>
      <author>tre2003@med.cornell.edu (Miriam Gordillo)</author>
      <author>tre2003@med.cornell.edu (Neranjan de Silva)</author>
      <author>tre2003@med.cornell.edu (Ritu Kumar)</author>
      <author>tre2003@med.cornell.edu (Todd Evans)</author>
      <author>tre2003@med.cornell.edu (Wendy K Chung)</author>
      <author>tre2003@med.cornell.edu (Zhong-Dong Shi)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.100797</guid>
      <category>Developmental Biology</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Thu, 13 Mar 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-03-13T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Single-nucleus transcriptomics reveal the cytological mechanism of conjugated linoleic acids in regulating intramuscular fat deposition</title>
      <link>https://elifesciences.org/articles/99790</link>
      <description>Conjugated linoleic acids (CLAs) can serve as a nutritional intervention to regulate quality, function, and fat infiltration in skeletal muscles, but the specific cytological mechanisms remain unknown. Here, we applied single-nucleus RNA-sequencing (snRNA-seq) to characterize the cytological mechanism of CLAs regulates fat infiltration in skeletal muscles based on pig models. We investigated the regulatory effects of CLAs on cell populations and molecular characteristics in pig muscles and found CLAs could promote the transformation of fast glycolytic myofibers into slow oxidative myofibers. We also observed three subpopulations including SCD&lt;sup&gt;+&lt;/sup&gt;/DGAT2&lt;sup&gt;+&lt;/sup&gt;, FABP5&lt;sup&gt;+&lt;/sup&gt;/SIAH1&lt;sup&gt;+&lt;/sup&gt;, and PDE4D&lt;sup&gt;+&lt;/sup&gt;/PDE7B&lt;sup&gt;+&lt;/sup&gt; subclusters in adipocytes and CLAs could increase the percentage of SCD&lt;sup&gt;+&lt;/sup&gt;/DGAT2&lt;sup&gt;+&lt;/sup&gt; adipocytes. RNA velocity analysis showed FABP5&lt;sup&gt;+&lt;/sup&gt;/SIAH1&lt;sup&gt;+&lt;/sup&gt; and PDE4D&lt;sup&gt;+&lt;/sup&gt;/PDE7B&lt;sup&gt;+&lt;/sup&gt; adipocytes could differentiate into SCD&lt;sup&gt;+&lt;/sup&gt;/DGAT2&lt;sup&gt;+&lt;/sup&gt; adipocytes. We further verified the differentiated trajectory of mature adipocytes and identified PDE4D&lt;sup&gt;+&lt;/sup&gt;/PDE7B&lt;sup&gt;+&lt;/sup&gt; adipocytes could differentiate into SCD&lt;sup&gt;+&lt;/sup&gt;/DGAT2&lt;sup&gt;+&lt;/sup&gt; and FABP5&lt;sup&gt;+&lt;/sup&gt;/SIAH1&lt;sup&gt;+&lt;/sup&gt; adipocytes by using high intramuscular fat (IMF) content Laiwu pig models. The cell-cell communication analysis identified the interaction network between adipocytes and other subclusters such as fibro/adipogenic progenitors (FAPs). Pseudotemporal trajectory analysis and RNA velocity analysis also showed FAPs could differentiate into PDE4D&lt;sup&gt;+&lt;/sup&gt;/PDE7B&lt;sup&gt;+&lt;/sup&gt; preadipocytes and we discovered the differentiated trajectory of preadipocytes into mature adipocytes. Besides, we found CLAs could promote FAPs differentiate into SCD&lt;sup&gt;+&lt;/sup&gt;/DGAT2&lt;sup&gt;+&lt;/sup&gt; adipocytes via inhibiting c-Jun N-terminal kinase (JNK) signaling pathway in vitro. This study provides a foundation for regulating fat infiltration in skeletal muscles by using nutritional strategies and provides potential opportunities to serve pig as an animal model to study human fat infiltrated diseases.</description>
      <author>zhouyanbing@zju.edu.cn (Liyi Wang)</author>
      <author>zhouyanbing@zju.edu.cn (Shiqi Liu)</author>
      <author>zhouyanbing@zju.edu.cn (Shu Zhang)</author>
      <author>zhouyanbing@zju.edu.cn (Tizhong Shan)</author>
      <author>zhouyanbing@zju.edu.cn (Yanbing Zhou)</author>
      <author>zhouyanbing@zju.edu.cn (Yizhen Wang)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.99790</guid>
      <category>Cell Biology</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Fri, 07 Mar 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-03-07T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
    <item>
      <title>Sphingosine-1-phosphate signaling regulates the ability of Müller glia to become neurogenic, proliferating progenitor-like cells</title>
      <link>https://elifesciences.org/articles/102151</link>
      <description>The purpose of these studies is to investigate how Sphingosine-1-phosphate (S1P) signaling regulates glial phenotype, dedifferentiation of Müller glia (MG), reprogramming into proliferating MG-derived progenitor cells (MGPCs), and neuronal differentiation of the progeny of MGPCs in the chick retina. We found that S1P-related genes are highly expressed by retinal neurons and glia, and levels of expression were dynamically regulated following retinal damage. Drug treatments that activate S1P receptor 1 (S1PR1) or increase levels of S1P suppressed the formation of MGPCs. Conversely, treatments that inhibit S1PR1 or decrease levels of S1P stimulated the formation of MGPCs. Inhibition of S1P receptors or S1P synthesis significantly enhanced the neuronal differentiation of the progeny of MGPCs. We report that S1P-related gene expression in MG is modulated by microglia and inhibition of S1P receptors or S1P synthesis partially rescues the loss of MGPC formation in damaged retinas missing microglia. Finally, we show that TGFβ/Smad3 signaling in the resting retina maintains S1PR1 expression in MG. We conclude that the S1P signaling is dynamically regulated in MG and MGPCs in the chick retina, and activation of S1P signaling depends, in part, on signals produced by reactive microglia.</description>
      <author>Andrew.Fischer@osumc.edu (Andy J Fischer)</author>
      <author>Andrew.Fischer@osumc.edu (Chengyu Gao)</author>
      <author>Andrew.Fischer@osumc.edu (Heithem M El-Hodiri)</author>
      <author>Andrew.Fischer@osumc.edu (Nicholas DeGroff)</author>
      <author>Andrew.Fischer@osumc.edu (Olivia B Taylor)</author>
      <guid isPermaLink="false">https://dx.doi.org/10.7554/eLife.102151</guid>
      <category>Developmental Biology</category>
      <category>Stem Cells and Regenerative Medicine</category>
      <pubDate>Thu, 06 Mar 2025 00:00:00 +0000</pubDate>
      <dc:date>2025-03-06T00:00:00Z</dc:date>
      <webfeeds:featuredImage url="https://elife-cdn.s3.amazonaws.com/observer/elife-logo-408x230.svg" height="230" width="408" type="image/svg"/>
    </item>
  </channel>
</rss>
